$GNSS

Genasys Inc.

No enriched coverage for $GNSS in the last 7 days.

No SEC Form 4 filings for $GNSS in the last 30 days.

Med

Genasys (GNSS) director granted 48,498 restricted stock units as equity pay

Genasys Inc. director Lawrence F. Hagenbuch was granted 48,498 restricted stock units (RSUs) as part of his compensation, with each RSU representing one share of common stock. These RSUs have no cash exercise price and will vest on the earlier of the company's 2027 annual shareholder meeting or a change of control. This grant increases Hagenbuch's direct holdings to 48,498 shares/share-settled units, aligning his interests with shareholder equity performance.

Genasys Inc. elects board members and approves auditor at annual meeting

Genasys Inc. held its Annual Meeting of Stockholders, electing five directors to one-year terms and ratifying Baker Tilly US, LLP as its independent auditor for the fiscal year ending September 30, 2026. Shareholders also approved the compensation of named executive officers on an advisory basis. The company recently reported a 146% increase in Q1 2026 revenue but missed earnings expectations.

Genasys sets 2026 compensation plan for CEO Richard Danforth

Genasys Inc. has approved the 2026 fiscal year compensation package for CEO Richard Danforth, which includes a base salary of $490,000 and a potential cash bonus tied to revenue, annual recurring revenue (ARR), and debt repayment targets. The package also features 400,000 restricted stock units (RSUs), split between time-based and performance-based vesting, while previous performance-based options were canceled. This announcement comes amid financial challenges for the company and follows recent news of a larger-than-expected loss per share in Q4 2025 and progress on a $75 million emergency warning system project.

News on $GNSS